Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02945046 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) |
| First Submitted : | October 25, 2016 |
| First Submitted that Met QC Criteria : | October 25, 2016 |
| First Posted : | October 26, 2016 (Estimate) |
| Results First Submitted : | March 27, 2020 |
| Results First Submitted that Met QC Criteria : | March 27, 2020 |
| Results First Posted : | April 13, 2020 |
| Last Update Submitted that Met QC Criteria : | November 6, 2021 |
| Last Update Posted : | November 9, 2021 |